Express News | Ionis Pharmaceuticals Inc : Oppenheimer Raises Target Price to $78 From $75

Breakings17minutes ago

A Quick Look at Today's Ratings for Ionis Pharmaceuticals(IONS.US), With a Forecast Between $59 to $67

Futu NewsDec 21 21:00 · Ratings

Ionis Pharmaceuticals' Growth Prospects Bolstered by FDA Approval of Tryngolza

TipRanksDec 21 02:13

Sector Update: Health Care Stocks Mixed Premarket Friday

MT NewswiresDec 20 22:04

The Analyst Verdict: Ionis Pharmaceuticals In The Eyes Of 6 Experts

BenzingaDec 20 22:01

Needham Maintains Buy on Ionis Pharmaceuticals, Maintains $60 Price Target

BenzingaDec 20 20:18 · Ratings